DNMT3A and acute myeloid leukemia: Taken together, these results imply that dysregulated DNA methylation, achieved either through mutations in DNMT3A, IDH1/IDH2, TET2, or WT1, play an important role in the pathogenesis of a large proportion of AML patients.